HALOZYME THERAPEUTICS, INC. HALO Cash Flow

Halozyme therapeutics, inc. (HALO)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating activities:
Net (loss) income
-6,103	-34,397	-25,015	-14,624	1,796	-2,126	-27,850	-22,893	-27,461	123,882	2,749	-30,763	-32,897	-27,386	-28,946	-26,875	-19,816	4,318	-24,460	3,019	-15,108	-5,274	-20,280	-16,273	-26,548	-21,987	-19,292	-22,912	-19,288	-4,405	-20,005	-14,021	-15,119	-18,415	5,165	3,116	-9,635
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation
4,531	7,229	8,239	9,833	9,475	9,012	8,867	9,478	8,339	7,402	7,762	8,191	7,315	6,742	6,655	6,371	5,817	5,250	5,553	5,905	4,130	4,209	4,176	3,594	3,295	2,398	2,304	2,439	2,397	1,986	1,922	2,285	2,154	1,653	1,757	1,227	931
Depreciation and amortization
900	1,100	1,000	1,000	1,000	600	600	634	566	532	496	570	602	634	654	623	489	459	402	395	421	458	464	443	397	334	301	297	295	282	286	272	237	244	238	286	326
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-617	462	463	1,453	452	601	789	1,054	358	357	356	172	415	432	432	746	-881	284	283	470	-	-	-	-	-	-	-	-
Payment-in-kind Interest expense on long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-8,600	3,674	3,588	1,890	879	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of discounts on marketable securities, net
3,478	264	472	797	306	924	896	705	435	209	156	-46	-16	-12,679	-108	-184	-213	699	-151	-223	-325	-395	-375	-1,722	1,035	-300	-319	-315	-182	0	0	0	0	-	-	-	-
Gain (Loss) on Disposition of Property Plant Equipment
597	-	-	-	0	-	-	-	-	-	-	-	-	-8	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-13	-0	0	6	0	0	0	0
Contract with Customer, Liability, Revenue Recognized
606	-	-	-	499	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49	-	-	-	-
Deferral of unearned revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,979	-1,643	-950	-2,007	7,463	-993	-4,154	4,729	-235	13,276	-543	-3,201	-507	2,315	-577	1,731	508	-17,249	262	-731
Recognition of deferred revenue
-	-	-	-	-	499	499	0	1,834	2,320	1,869	600	1,723	1,199	4,851	1,730	1,524	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease payments deferred
-221	-155	-101	-110	-93	-85	-80	26	132	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Recognition of deferred rent
-	-	-	-	-	-	-	-	-	60	56	-45	114	110	93	97	70	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-4	-6	-9	-3	11	1	3	-11	-2	-54	-13	12	39	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable, net
-29,693	18,698	8,525	4,055	-1,841	2,349	-5,926	7,008	-15,044	7,438	222	2,021	-3,228	-1,998	-5,549	-2,316	-6,867	24,018	-1,346	2,013	-1,424	874	-4,620	1,939	1,859	-15,425	13,690	456	-5,327	11,239	-1,222	136	3,288	-3,975	1,742	2,764	-596
Inventories
12,093	-6,692	-7,849	12,659	8,616	4,341	9,881	4,010	-752	-4,185	-5,841	882	-333	1,771	2,097	410	856	-1,612	3,378	241	1,076	-510	-198	349	595	2,323	1,380	-271	67	484	402	287	929	463	19	-164	55
Prepaid expenses and other assets
-3,833	4,696	770	12,722	818	-1,782	-1,676	3,214	5,939	6,963	-1,309	-3,021	-4,668	-4,541	-965	-2,642	2,522	14,774	-436	593	843	363	674	-1,024	252	59	-1,964	1,157	-1,211	1,399	1,134	1,308	577	4,034	596	318	-337
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	100	-50	0	0	0	-	-	-	-
Accounts payable and accrued expenses
-27,621	11,447	-8,496	9,568	-7,881	9,062	2,823	5,455	-11,644	12,552	3,534	4,922	-5,379	1,157	3,410	-246	-4,565	7,855	4,320	2,900	-1,209	-2,509	-1,481	-245	3,419	-8,183	3,541	10,549	1,981	-1,156	1,494	7	-3,609	2,895	-1,100	1,688	-2,771
Other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-69	-63	-68	-	-20	-21	73	-9	-41	-41	43	-	-	-	-	82	104	74	-89
Net cash provided by (used in) operating activities
-4,844	-26,625	-29,588	-24,786	-4,424	10,462	-18,927	-18,858	-22,177	153,249	20,259	-16,996	-22,459	-15,767	-8,748	-12,845	-13,023	-15,197	-16,985	8,938	-13,839	-939	-13,183	-15,766	-17,630	-15,220	-12,414	-10,955	-10,750	-16,868	-14,298	-13,755	-19,357	-13,503	-13,443	3,738	-11,092
Investing activities:
Purchases of marketable securities
63,257	148,177	7,898	66,014	167,670	38,469	62,728	95,254	114,661	199,439	36,856	107,062	54,830	3,008	14,005	11,968	126,431	25,122	13,176	-1	33,185	-233	1	24,111	65,005	0	0	0	48,947	0	0	0	0	-	-	-	-
Proceeds from maturities of marketable securities
100,742	26,000	50,001	114,839	197,410	52,351	98,252	88,065	79,600	51,311	67,300	58,000	59,194	24,500	22,675	12,700	21,908	12,000	33,805	11,030	22,895	13,485	3,000	18,591	22,225	3,375	0	0	0	-	-	-	-	-	-	-	-
Purchases of property and equipment
114	641	1,104	1,368	927	3,073	333	418	839	860	161	230	99	447	424	1,167	1,099	1,634	336	260	130	236	371	350	411	1,358	325	80	534	539	167	705	0	556	38	29	203
Proceeds from Sale of Property, Plant, and Equipment
738	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	-	-	-	-
Net cash (used in) provided by investing activities
38,109	-122,818	40,999	47,457	28,813	10,809	35,191	-7,607	-35,900	-148,988	30,283	-49,292	4,265	21,045	8,246	-435	-105,622	-14,756	20,293	10,771	-10,420	13,482	2,628	-5,870	-43,191	2,017	-325	-80	-49,481	-539	-167	-721	15	-556	-38	-29	-203
Financing activities:
Proceeds from issuance of common stock, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	107,713	0	0	0	0	0	0	0	81,476	-	-	-	-
Proceeds from issuance of long-term debt, net
-	-	-	-	-	-	-	-	-	-	-	-	-	1	0	54,959	148,046	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of long-term debt
16,699	44,784	21,325	20,692	21,281	20,417	19,956	19,515	17,628	5,007	4,595	3,404	2,989	-35	35	50,365	3,885	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of Debt Issuance Costs
68	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments for Repurchase of Common Stock
51,574	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	65	309	-	-	347	0	-	-	-	-
Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement
19,717	8,131	2,075	4,467	-449	2,063	3,538	3,141	4,977	5,090	3,703	4,376	-393	243	511	826	285	1,731	437	3,773	7,157	2,471	795	1,201	2,321	3,083	1,929	10	57	83	-308	257	1,647	-	-	-	1,868
Net cash provided by financing activities
-48,624	210,420	-19,250	-16,225	-21,730	-18,354	-16,418	-16,374	-12,651	82	-890	135,845	-3,382	279	476	5,420	144,446	1,731	437	3,773	7,157	2,471	795	1,201	110,034	23,068	2,303	-55	-252	29,744	38	-90	83,124	606	695	1,578	1,868
Net increase (decrease) in cash, cash equivalents and restricted cash
-15,359	60,977	-7,839	6,446	2,659	2,917	-154	-42,839	-70,728	4,343	49,652	69,557	-21,576	5,557	-26	-7,860	25,801	-28,222	3,745	23,482	-17,102	15,014	-9,760	-20,435	49,213	9,865	-10,436	-11,090	-60,483	12,336	-14,426	-14,566	63,782	-13,453	-12,787	5,287	-9,426
Supplemental disclosure of cash flow information:
Interest Paid, Including Capitalized Interest, Operating and Investing Activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19	0	0	0	-	-	-	-
Supplemental disclosure of non-cash investing and financing activities:
Amounts accrued for purchases of property and equipment
347	-190	-294	345	200	-1,803	2,280	-112	177	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-354	465	-585	628	182	-21	11	16
Right-of-use assets obtained in exchange for lease obligation
1,589	0	732	0	165	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments for Tenant Improvements
-	-	-	-	-	0	0	0	1,322	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-